These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10703939)

  • 1. Platelet-osteosarcoma cell interaction is mediated through a specific fibrinogen-binding sequence located within the N-terminal domain of thrombospondin 1.
    Voland C; Serre CM; Delmas P; Clézardin P
    J Bone Miner Res; 2000 Feb; 15(2):361-8. PubMed ID: 10703939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
    Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
    J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin binds to the surface of human osteosarcoma cells and mediates platelet-osteosarcoma cell interaction.
    Clezardin P; Serre CM; Trzeciak MC; Drouin J; Delmas PD
    Cancer Res; 1991 May; 51(10):2621-7. PubMed ID: 1708697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
    Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
    J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: evaluation by two novel binding assays.
    Majluf-Cruz A; Manns JM; Uknis AB; Yang X; Colman RW; Harris RB; Frazier W; Lawler J; DeLa Cadena RA
    J Lab Clin Med; 2000 Oct; 136(4):292-302. PubMed ID: 11039850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans.
    Wang S; Herndon ME; Ranganathan S; Godyna S; Lawler J; Argraves WS; Liau G
    J Cell Biochem; 2004 Mar; 91(4):766-76. PubMed ID: 14991768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60).
    Dimitriou AA; Stathopoulos P; Mitsios JV; Sakarellos-Daitsiotis M; Goudevenos J; Tsikaris V; Tselepis AD
    Platelets; 2009 Dec; 20(8):539-47. PubMed ID: 19863457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro.
    Carron JA; Wagstaff SC; Gallagher JA; Bowler WB
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1124-7. PubMed ID: 10772961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion of osteosarcoma cells to the 70-kDa core region of thrombospondin-1 is mediated by the alpha 4 beta 1 integrin.
    Decker S; van Valen F; Vischer P
    Biochem Biophys Res Commun; 2002 Apr; 293(1):86-92. PubMed ID: 12054567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombospondin and the adhesive behavior of platelets.
    Santoro SA
    Semin Thromb Hemost; 1987 Jul; 13(3):290-7. PubMed ID: 3686021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin-1.
    Zhou J; Rothman VL; Sargiannidou I; Dimitrov S; Qiu C; Smith E; Sheffield J; Sharma M; Tuszynski GP
    J Cell Biochem; 2004 May; 92(1):125-46. PubMed ID: 15095410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombospondin-1 (TSP-1) and TSP-1-derived heparin-binding peptides induce promyelocytic leukemia cell differentiation and apoptosis.
    Bruel A; Touhami-Carrier M; Thomaidis A; Legrand C
    Anticancer Res; 2005; 25(2A):757-64. PubMed ID: 15868907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumococcal association to platelets is mediated by soluble fibrin and supported by thrombospondin-1.
    Niemann S; Kehrel BE; Heilmann C; Rennemeier C; Peters G; Hammerschmidt S
    Thromb Haemost; 2009 Oct; 102(4):735-42. PubMed ID: 19806260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cell adhesive active sites in the N-terminal domain of thrombospondin-1.
    Clezardin P; Lawler J; Amiral J; Quentin G; Delmas P
    Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):819-27. PubMed ID: 9032471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model of platelet aggregation involving multiple interactions of thrombospondin-1, fibrinogen, and GPIIbIIIa receptor.
    Bonnefoy A; Hantgan R; Legrand C; Frojmovic MM
    J Biol Chem; 2001 Feb; 276(8):5605-12. PubMed ID: 11094060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin.
    Legrand C; Morandi V; Mendelovitz S; Shaked H; Hartman JR; Panet A
    Arterioscler Thromb; 1994 Nov; 14(11):1784-91. PubMed ID: 7947604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of human platelet thrombospondin with fibrinogen. Thrombospondin purification and specificity of interaction.
    Tuszynski GP; Srivastava S; Switalska HI; Holt JC; Cierniewski CS; Niewiarowski S
    J Biol Chem; 1985 Oct; 260(22):12240-5. PubMed ID: 3930491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: modulation of platelet aggregation.
    Legrand C; Thibert V; Dubernard V; Bégault B; Lawler J
    Blood; 1992 Apr; 79(8):1995-2003. PubMed ID: 1562725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.